Artwork

Content provided by Dr. Tim Sayed. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Tim Sayed or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep. 8 - The Hidden Cost Of Ozempic: What You’re Not Being Told About Muscle Loss, Motivation & Metabolism

14:39
 
Share
 

Manage episode 478446718 series 3635298
Content provided by Dr. Tim Sayed. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Tim Sayed or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this eye-opening episode of The Scalpel’s Edge, double board-certified plastic surgeon Dr. Tim Sayed pulls back the curtain on the dark side of GLP-1 drugs like Ozempic and semaglutide. While these medications are hailed for their dramatic weight loss results, Dr. Sayed explores the less-discussed truth—up to 40% of that weight loss may actually be muscle mass. He dives into the science behind this phenomenon, the rising role of peptides like ipamorelin, and biotech innovations like myostatin inhibitors aimed at preserving strength while shedding fat.

But this conversation isn’t just clinical—it’s personal. Dr. Sayed shares how journaling, digital scales, and patient-doctor goal alignment can reignite motivation during a weight loss journey. From cutting-edge research in Korea to the controversial use of performance-enhancing peptides, this episode is a compelling look at how we can lose the fat without sacrificing our bodies. If you or someone you know is on or considering GLP-1 medications, this is the episode you can’t afford to miss.

Contact Dr. Tim Sayed:
Phone:
(858) 247-2933
Email: [email protected]
Website: timsayedmd.com
Instagram: @timsayedmd
YouTube: @Timsayedmd
Facebook: Tim Sayed MD

  continue reading

9 episodes

Artwork
iconShare
 
Manage episode 478446718 series 3635298
Content provided by Dr. Tim Sayed. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Tim Sayed or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

In this eye-opening episode of The Scalpel’s Edge, double board-certified plastic surgeon Dr. Tim Sayed pulls back the curtain on the dark side of GLP-1 drugs like Ozempic and semaglutide. While these medications are hailed for their dramatic weight loss results, Dr. Sayed explores the less-discussed truth—up to 40% of that weight loss may actually be muscle mass. He dives into the science behind this phenomenon, the rising role of peptides like ipamorelin, and biotech innovations like myostatin inhibitors aimed at preserving strength while shedding fat.

But this conversation isn’t just clinical—it’s personal. Dr. Sayed shares how journaling, digital scales, and patient-doctor goal alignment can reignite motivation during a weight loss journey. From cutting-edge research in Korea to the controversial use of performance-enhancing peptides, this episode is a compelling look at how we can lose the fat without sacrificing our bodies. If you or someone you know is on or considering GLP-1 medications, this is the episode you can’t afford to miss.

Contact Dr. Tim Sayed:
Phone:
(858) 247-2933
Email: [email protected]
Website: timsayedmd.com
Instagram: @timsayedmd
YouTube: @Timsayedmd
Facebook: Tim Sayed MD

  continue reading

9 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Listen to this show while you explore
Play